174 related articles for article (PubMed ID: 29923106)
21. Economic, ethical, and environmental sustainability of cardiac imaging.
Picano E
Eur Heart J; 2023 Dec; 44(45):4748-4751. PubMed ID: 36477859
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
23. Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography.
Waller AH; Blankstein R; Kwong RY; Di Carli MF
Curr Cardiol Rep; 2014 May; 16(5):483. PubMed ID: 24718671
[TBL] [Abstract][Full Text] [Related]
24. Multimodality imaging of heart valve disease.
Rajani R; Khattar R; Chiribiri A; Victor K; Chambers J
Arq Bras Cardiol; 2014 Sep; 103(3):251-63. PubMed ID: 24830387
[TBL] [Abstract][Full Text] [Related]
25. PET-based imaging to detect and characterize cardiovascular disorders: Unavoidable path for the foreseeable future.
Alavi A; Werner TJ; Høilund-Carlsen PF
J Nucl Cardiol; 2018 Feb; 25(1):203-207. PubMed ID: 28900846
[No Abstract] [Full Text] [Related]
26. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
27. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making.
Dowsley T; Al-Mallah M; Ananthasubramaniam K; Dwivedi G; McArdle B; Chow BJ
Can J Cardiol; 2013 Mar; 29(3):285-96. PubMed ID: 23357601
[TBL] [Abstract][Full Text] [Related]
28. Brown adipose tissue in humans: detection and functional analysis using PET (positron emission tomography), MRI (magnetic resonance imaging), and DECT (dual energy computed tomography).
Borga M; Virtanen KA; Romu T; Leinhard OD; Persson A; Nuutila P; Enerbäck S
Methods Enzymol; 2014; 537():141-59. PubMed ID: 24480345
[TBL] [Abstract][Full Text] [Related]
29. [Cardiac sarcoidosis: seven keypoints to remind in order to avoid misdiagnosis].
Porretta AP; Van der Gucht A; Bisch L; Mitsakis P; Pomoni A; Allenbach G; Lalonde MN; Schaefer N; Buss G; Prior JO; Pruvot É
Rev Med Suisse; 2016 May; 12(520):1035-6, 1038-41. PubMed ID: 27424343
[TBL] [Abstract][Full Text] [Related]
30. Technical Aspects of Cardiac PET Imaging and Recent Advances.
Germano G; Berman DS; Slomka P
Cardiol Clin; 2016 Feb; 34(1):13-23. PubMed ID: 26590776
[TBL] [Abstract][Full Text] [Related]
31. The Year in Cardiology 2012: imaging, computed tomography, and cardiovascular magnetic resonance.
Peebles C
Eur Heart J; 2013 Jan; 34(4):310-3. PubMed ID: 23284095
[TBL] [Abstract][Full Text] [Related]
32. Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM).
Nensa F; Bamberg F; Rischpler C; Menezes L; Poeppel TD; la Fougère C; Beitzke D; Rasul S; Loewe C; Nikolaou K; Bucerius J; Kjaer A; Gutberlet M; Prakken NH; Vliegenthart R; Slart RHJA; Nekolla SG; Lassen ML; Pichler BJ; Schlosser T; Jacquier A; Quick HH; Schäfers M; Hacker M; ;
Eur Radiol; 2018 Oct; 28(10):4086-4101. PubMed ID: 29717368
[TBL] [Abstract][Full Text] [Related]
33. Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.
White JA; Rajchl M; Butler J; Thompson RT; Prato FS; Wisenberg G
Circulation; 2013 Jun; 127(22):e639-41. PubMed ID: 23733970
[No Abstract] [Full Text] [Related]
34. Advances in the understanding of the pathophysiology and management of aortic stenosis: role of novel imaging techniques.
Singh A; Steadman CD; McCann GP
Can J Cardiol; 2014 Sep; 30(9):994-1003. PubMed ID: 25015690
[TBL] [Abstract][Full Text] [Related]
35. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
Raman SP; Horton KM; Fishman EK
Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
[TBL] [Abstract][Full Text] [Related]
36. Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging.
von Olshausen G; Hyafil F; Langwieser N; Laugwitz KL; Schwaiger M; Ibrahim T
Circulation; 2014 Sep; 130(11):925-6. PubMed ID: 25199667
[No Abstract] [Full Text] [Related]
37. Imaging heart failure: current and future applications.
Paterson I; Mielniczuk LM; O'Meara E; So A; White JA
Can J Cardiol; 2013 Mar; 29(3):317-28. PubMed ID: 23439018
[TBL] [Abstract][Full Text] [Related]
38. Cardiac tumors: the role of cardiovascular imaging.
Bhattacharyya S; Khattar RS; Gujral DM; Senior R
Expert Rev Cardiovasc Ther; 2014 Jan; 12(1):37-43. PubMed ID: 24345096
[TBL] [Abstract][Full Text] [Related]
39. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2022: positron emission tomography, computed tomography, and magnetic resonance.
Murphy J; AlJaroudi WA; Hage FG
J Nucl Cardiol; 2023 Jun; 30(3):941-954. PubMed ID: 37204688
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular PET/MRI: Challenges and Opportunities.
LaForest R; Woodard PK; Gropler RJ
Cardiol Clin; 2016 Feb; 34(1):25-35. PubMed ID: 26590777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
